510(k) K772255
K772255 is an FDA 510(k) premarket notification submitted by Kallestad Laboratories, Inc. for the device "CERULOPLASMIN NEPHEL. ASSAY". The FDA issued a decision of Substantially Equivalent on Jan 5, 1978. The device falls under product code DDB (Ceruloplasmin, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5210. Kallestad Laboratories, Inc. has 91 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jan 5, 1978
- Date Received
- Dec 9, 1977
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Ceruloplasmin, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5210
- Review Panel
- IM
- Submission Type
- 510(k) Exempt
Need the full FDA record for Kallestad Laboratories, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.